Clinical trials for Angelman syndrome due to a point mutation
9 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGNCT07417137A Natural History Study of Angelman SyndromeMassachusetts General Hospital · PI: Christopher J Keary, MD
- RECRUITINGPHASE1, PHASE2NCT07181837A Phase 1/2 Study of the Safety and Efficacy of MVX-220 in Angelman SyndromeMavriX Bio, LLC
- RECRUITINGPhase 2NCT07157254A Safety and Efficacy Study of GTX-102 in Subjects With Deletion- or Nondeletion-type Angelman Syndrome (AS)Ultragenyx Pharmaceutical Inc · PI: Medical Director
- RECRUITINGNCT06737718Use of Eye Tracking to Study Social Perception Abnormalities in Children With Angelman SyndromeAssistance Publique - Hôpitaux de Paris · PI: Nathalie MD, PhD Boddaert
- ACTIVE NOT RECRUITINGPhase 3NCT06617429Phase 3 Efficacy and Safety Study of GTX-102 in Pediatric Subjects With Angelman Syndrome (AS)Ultragenyx Pharmaceutical Inc · PI: Medical Director
- ENROLLING BY INVITATIONPhase 3NCT06415344Long-term Extension of GTX-102 in Angelman SyndromeUltragenyx Pharmaceutical Inc · PI: Medical Director
- RECRUITINGPHASE1, PHASE2NCT05127226HALOS: A Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Multiple Ascending Doses of ION582 in Participants With Angelman SyndromeIonis Pharmaceuticals, Inc.
- RECRUITINGNCT06229769Natural History Study for Patients With Angelman SyndromeCentre Hospitalier Universitaire de Liege · PI: Laura Vanden Brande
- RECRUITINGNCT05293184The Global Angelman Syndrome RegistryFoundation for Angelman Syndrome Therapeutics, Australia · PI: Helen (Honey) Heussler, MBBS, FRACP DM